CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 80 filers reported holding CATALYST BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,297,000 | -10.9% | 301,678 | +21.6% | 0.62% | -1.3% |
| Q2 2020 | $1,456,000 | -13.0% | 248,050 | -35.2% | 0.62% | -20.1% |
| Q1 2020 | $1,673,000 | -37.3% | 382,900 | -2.3% | 0.78% | -33.3% |
| Q4 2019 | $2,669,000 | -2.6% | 391,894 | -29.8% | 1.17% | -22.9% |
| Q3 2019 | $2,741,000 | -32.0% | 558,159 | +2.0% | 1.52% | -25.2% |
| Q2 2019 | $4,032,000 | +2.7% | 547,092 | +13.0% | 2.03% | +18.3% |
| Q1 2019 | $3,927,000 | +6.6% | 484,200 | +3.7% | 1.72% | -9.7% |
| Q4 2018 | $3,684,000 | +44.5% | 466,900 | +97.4% | 1.90% | +33.8% |
| Q3 2018 | $2,550,000 | – | 236,558 | – | 1.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 471,448 | $5,502,000 | 3.04% |
| ACUTA CAPITAL PARTNERS, LLC | 830,000 | $9,686,000 | 1.72% |
| NEXTHERA CAPITAL LP | 786,865 | $9,183,000 | 1.42% |
| Ghost Tree Capital, LLC | 355,000 | $4,143,000 | 1.22% |
| Point72 Europe (London) LLP | 83,500 | $974,000 | 0.52% |
| Virtus ETF Advisers LLC | 31,061 | $362,000 | 0.32% |
| Eventide Asset Management | 246,000 | $2,871,000 | 0.12% |
| Kalos Management, Inc. | 8,500 | $244,000 | 0.11% |
| MARSHALL WACE, LLP | 550,352 | $6,423,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 157,145 | $1,834,000 | 0.09% |